| NCT03407313 |
CONFORM: Rotational Fractional Resection for Submental Contouring |
https://ClinicalTrials.gov/show/NCT03407313 |
Completed |
Recros Medica, Inc. |
2018-12-28 |
| NCT03936829 |
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT03936829 |
Recruiting |
Children’s Hospital of Fudan University |
2021-05-31 |
| NCT03275259 |
Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat |
https://ClinicalTrials.gov/show/NCT03275259 |
Completed |
Indústria Brasileira Equipamentos Médicos - IBRAMED |
2018-01-01 |
| NCT03226821 |
Body Composition and Adipose Tissue in HIV |
https://ClinicalTrials.gov/show/NCT03226821 |
Recruiting |
Columbia University |
2021-04-30 |
| NCT03075332 |
Detraining in People Living With HIV/AIDS |
https://ClinicalTrials.gov/show/NCT03075332 |
Completed |
Universidade Federal do Rio Grande do Norte |
2016-06-21 |
| NCT03050749 |
Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars |
https://ClinicalTrials.gov/show/NCT03050749 |
Completed |
Croma-Pharma GmbH |
2017-10-18 |
| NCT03050723 |
Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars |
https://ClinicalTrials.gov/show/NCT03050723 |
Completed |
Croma-Pharma GmbH |
2017-07-17 |
| NCT03039491 |
Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults |
https://ClinicalTrials.gov/show/NCT03039491 |
Completed |
Medical University of South Carolina |
2020-03-30 |
| NCT02914886 |
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) |
https://ClinicalTrials.gov/show/NCT02914886 |
Completed |
Kinderkrankenhaus auf der Bult |
2019-04-30 |
| NCT02858830 |
Familial Partial Lipodystrophy Study |
https://ClinicalTrials.gov/show/NCT02858830 |
Active, not recruiting |
Mayo Clinic |
2018-02-28 |
| NCT02743403 |
Effects of TENS in Pain During Application of Carboxytherapy in Patients With Gynoid Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02743403 |
Completed |
Universidade Cidade de Sao Paulo |
2016-04-30 |
| NCT02684591 |
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02684591 |
Completed |
University of California, San Diego |
2018-02-28 |
| NCT02654977 |
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02654977 |
Active, not recruiting |
University of Michigan |
2020-02-29 |
| NCT02647853 |
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02647853 |
Completed |
Topokine Therapeutics, Inc. |
2014-12-31 |
| NCT02639286 |
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension |
https://ClinicalTrials.gov/show/NCT02639286 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-09-26 |
| NCT02527343 |
The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02527343 |
Active, not recruiting |
Ionis Pharmaceuticals, Inc. |
2018-06-30 |
| NCT02492997 |
Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference |
https://ClinicalTrials.gov/show/NCT02492997 |
Completed |
Venus Concept |
2016-10-31 |
| NCT02430077 |
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients |
https://ClinicalTrials.gov/show/NCT02430077 |
Recruiting |
University of Texas Southwestern Medical Center |
2020-09-30 |
| NCT02404896 |
Expanded Access Metreleptin Study |
https://ClinicalTrials.gov/show/NCT02404896 |
Active, not recruiting |
University of Michigan |
2025-01-31 |
| NCT02342223 |
Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy |
https://ClinicalTrials.gov/show/NCT02342223 |
Completed |
VA Northern California Health Care System |
2016-05-31 |
| NCT02262832 |
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02262832 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-07-31 |
| NCT02262806 |
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02262806 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-07-31 |
| NCT02056912 |
Identification of a New Gene Involved in Hereditary Lipodystrophy |
https://ClinicalTrials.gov/show/NCT02056912 |
Completed |
University Hospital, Bordeaux |
2014-01-31 |
| NCT01778556 |
Short-term Effects of Leptin in People With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT01778556 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-02-23 |
| NCT01679197 |
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT01679197 |
Completed |
University of Michigan |
2016-07-13 |
| NCT01671839 |
Study of the Cabochon System for Improvement in the Appearance of Cellulite |
https://ClinicalTrials.gov/show/NCT01671839 |
Completed |
Merz North America, Inc. |
2013-09-30 |
| NCT01612858 |
Metabolic Abnormalities in HIV-infected Persons |
https://ClinicalTrials.gov/show/NCT01612858 |
Completed |
Tufts Medical Center |
2014-11-30 |
| NCT01511016 |
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome |
https://ClinicalTrials.gov/show/NCT01511016 |
Completed |
Baylor College of Medicine |
2011-06-30 |
| NCT04159415 |
Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy |
https://ClinicalTrials.gov/show/NCT04159415 |
Active, not recruiting |
Regeneron Pharmaceuticals |
2021-05-31 |
| NCT04026178 |
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy |
https://ClinicalTrials.gov/show/NCT04026178 |
Recruiting |
Aegerion Pharmaceuticals, Inc. |
2022-01-31 |
| NCT03986983 |
Shockwave Therapy (SWT) |
https://ClinicalTrials.gov/show/NCT03986983 |
Completed |
Escola Superior de Tecnologia da Saúde do Porto |
2019-07-26 |
| NCT03966924 |
The PREFORM Study: A Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring |
https://ClinicalTrials.gov/show/NCT03966924 |
Completed |
Recros Medica, Inc. |
2019-10-16 |
| NCT03514420 |
Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With With Familial Partial Lipodystrophy (FPL) |
https://ClinicalTrials.gov/show/NCT03514420 |
Completed |
Akcea Therapeutics |
2019-07-30 |
| NCT03508687 |
Study of Gemcabene in Adults With FPLD |
https://ClinicalTrials.gov/show/NCT03508687 |
Completed |
University of Michigan |
2019-07-31 |
| NCT03445351 |
Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS |
https://ClinicalTrials.gov/show/NCT03445351 |
Completed |
Universidade Federal do Rio Grande do Norte |
2015-04-22 |
| NCT01263717 |
Effects of Growth Hormone Releasing Hormone in HIV |
https://ClinicalTrials.gov/show/NCT01263717 |
Completed |
Massachusetts General Hospital |
2014-02-28 |
| NCT01077765 |
Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy |
https://ClinicalTrials.gov/show/NCT01077765 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-07-31 |
| NCT01023620 |
HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) |
https://ClinicalTrials.gov/show/NCT01023620 |
Completed |
University of Texas Southwestern Medical Center |
2010-05-31 |
| NCT00978237 |
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT00978237 |
Completed |
Hospital Clinic of Barcelona |
2013-11-30 |
| NCT00931268 |
Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane |
https://ClinicalTrials.gov/show/NCT00931268 |
Completed |
Q-Med AB |
2011-09-30 |
| NCT00896298 |
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00896298 |
Completed |
University of Texas Southwestern Medical Center |
2014-11-30 |
| NCT00865007 |
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy |
https://ClinicalTrials.gov/show/NCT00865007 |
Completed |
Fundacion SEIMC-GESIDA |
2012-06-30 |
| NCT02009462 |
Artefill for the Treatment of HIV-associated Facial Lipoatrophy |
https://ClinicalTrials.gov/show/NCT02009462 |
Active, not recruiting |
AIDS Research and Treatment Center of the Treasure Coast |
2019-11-30 |
| NCT01828723 |
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells |
https://ClinicalTrials.gov/show/NCT01828723 |
Completed |
Antria |
2015-01-31 |
| NCT01848340 |
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01848340 |
Completed |
ViiV Healthcare |
2013-07-31 |
| NCT00677313 |
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00677313 |
Completed |
Bristol-Myers Squibb |
2015-01-31 |
| NCT00656851 |
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00656851 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2009-08-31 |
| NCT00656175 |
Raltegravir Therapy for Women With HIV and Fat Accumulation |
https://ClinicalTrials.gov/show/NCT00656175 |
Completed |
University of California, Los Angeles |
2011-12-31 |
| NCT00647946 |
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue |
https://ClinicalTrials.gov/show/NCT00647946 |
Completed |
Gilead Sciences |
2004-10-31 |
| NCT00646984 |
Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00646984 |
Completed |
Hospital Clinic of Barcelona |
2005-04-30 |
| NCT00639457 |
Exercise and Pioglitazone for HIV-Metabolic Syndromes |
https://ClinicalTrials.gov/show/NCT00639457 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2008-12-31 |
| NCT00627380 |
Yoga for the Management of HIV-Metabolic Syndromes |
https://ClinicalTrials.gov/show/NCT00627380 |
Completed |
Washington University School of Medicine |
2009-06-30 |
| NCT00608023 |
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00608023 |
Completed |
Theratechnologies |
2008-10-31 |
| NCT00585715 |
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening |
https://ClinicalTrials.gov/show/NCT00585715 |
Completed |
University of California, Irvine |
2009-12-31 |
| NCT00461552 |
Therapeutic Approaches to HAART-Induced Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00461552 |
Completed |
University of Texas Southwestern Medical Center |
2014-09-30 |
| NCT00457938 |
Novel Therapies for Metabolic Complications of Lipodystrophies |
https://ClinicalTrials.gov/show/NCT00457938 |
Completed |
University of Texas Southwestern Medical Center |
2014-11-30 |
| NCT00457665 |
Mechanisms of Lipodystrophy in HIV-Infected Pateints |
https://ClinicalTrials.gov/show/NCT00457665 |
Completed |
University of Texas Southwestern Medical Center |
2007-10-31 |
| NCT00457639 |
Cholic Acid for Hepatic Steatosis in Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00457639 |
Completed |
University of Texas Southwestern Medical Center |
2011-04-30 |
| NCT00383734 |
Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE |
https://ClinicalTrials.gov/show/NCT00383734 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
2008-09-30 |
| NCT00367744 |
Rosiglitazone Effect on Mitochondria and Lipoatrophy |
https://ClinicalTrials.gov/show/NCT00367744 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12-31 |
| NCT00362440 |
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00362440 |
Completed |
Beth Israel Deaconess Medical Center |
2011-05-31 |
| NCT00333684 |
Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid |
https://ClinicalTrials.gov/show/NCT00333684 |
Completed |
Canadian Immunodeficiency Research Collaborative |
2006-11-30 |
| NCT00312832 |
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00312832 |
Completed |
Hospital Clinic of Barcelona |
NA |
| NCT00307164 |
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy |
https://ClinicalTrials.gov/show/NCT00307164 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12-31 |
| NCT00246376 |
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00246376 |
Completed |
Baylor College of Medicine |
2009-09-30 |
| NCT00227500 |
Pravastatin for Hyperlipidaemia in HIV. |
https://ClinicalTrials.gov/show/NCT00227500 |
Completed |
Kirby Institute |
NA |
| NCT00202241 |
The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS |
https://ClinicalTrials.gov/show/NCT00202241 |
Completed |
Queen’s University |
NA |
| NCT00202228 |
Lactate Metabolism Study in HIV Infected Persons |
https://ClinicalTrials.gov/show/NCT00202228 |
Completed |
Queen’s University |
2008-10-31 |
| NCT00192660 |
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) |
https://ClinicalTrials.gov/show/NCT00192660 |
Completed |
Kirby Institute |
2006-10-31 |
| NCT00192621 |
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00192621 |
Completed |
Kirby Institute |
2006-12-31 |
| NCT00140244 |
Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00140244 |
Completed |
Beth Israel Deaconess Medical Center |
2011-06-30 |
| NCT00139178 |
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. |
https://ClinicalTrials.gov/show/NCT00139178 |
Completed |
Danish HIV Research Group |
NA |
| NCT00135356 |
Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome |
https://ClinicalTrials.gov/show/NCT00135356 |
Completed |
Bristol-Myers Squibb |
2007-07-31 |
| NCT00130286 |
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance |
https://ClinicalTrials.gov/show/NCT00130286 |
Completed |
Weill Medical College of Cornell University |
2010-08-31 |
| NCT00123253 |
TH9507 in Patients With HIV-Associated Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00123253 |
Completed |
Theratechnologies |
2006-11-30 |
| NCT00119769 |
The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients |
https://ClinicalTrials.gov/show/NCT00119769 |
Completed |
Hvidovre University Hospital |
2007-05-31 |
| NCT00119379 |
Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults |
https://ClinicalTrials.gov/show/NCT00119379 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-10-31 |
| NCT00100698 |
Physiologic Growth Hormone Effects in HIV Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00100698 |
Completed |
Massachusetts General Hospital |
2007-10-31 |
| NCT00082628 |
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients |
https://ClinicalTrials.gov/show/NCT00082628 |
Completed |
EMD Serono |
2005-09-28 |
| NCT00795210 |
Effects of Short-term Growth Hormone in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT00795210 |
Completed |
Massachusetts General Hospital |
2012-11-30 |
| NCT00028314 |
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients |
https://ClinicalTrials.gov/show/NCT00028314 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00025883 |
Leptin to Treat Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00025883 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-02-28 |
| NCT00021463 |
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects |
https://ClinicalTrials.gov/show/NCT00021463 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2002-02-28 |
| NCT00017758 |
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs |
https://ClinicalTrials.gov/show/NCT00017758 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00015691 |
Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities |
https://ClinicalTrials.gov/show/NCT00015691 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-01-31 |
| NCT00006412 |
Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids |
https://ClinicalTrials.gov/show/NCT00006412 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00005764 |
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT00005764 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002417 |
A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications |
https://ClinicalTrials.gov/show/NCT00002417 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00005905 |
Leptin to Treat Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00005905 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00006190 |
A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy |
https://ClinicalTrials.gov/show/NCT00006190 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00006185 |
Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome |
https://ClinicalTrials.gov/show/NCT00006185 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |